Therefore, in this study, we hypothesized that genetic variations of the FGF21 pathway are collectively associated with NAFLD risk, with the associations potentially modulated by protein intake level, which is a strong FGF21-pathway stimulus. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.